jueves, 22 de abril de 2010

WHO Pharmaceuticals Newsletter (No, 2, 2010)

Estimadas y estimados

ya salió el último número del WHO Pharmaceuticals Newsletter (No, 2, 2010).

con el siguiente contenido

Regulatory Matters

Becaplermin..........................................…....1

Clopidogrel ..................................................1

Clopidogrel and proton-pump inhibitors......1

Deferasirox...................................................2

Dextropropoxyphene...........................…….3

Didanosine....................................................3

Erythropoiesis-stimulating agents ………...4

Human immune globulin ...................…….4

Isotretinoin...................................................5

Long-acting beta-agonists ..............………..5

Natalizumab...............................................…6

Safety of Medicines

Cough and cold medicines ..............………..8

Fluoxetine......................................................8

H1N1 pandemic vaccines..................………8

Saquinavir.................................................….9

Seasonal flu vaccine.............................…….9

Serotonergic agents...........................……..10

Simvastatin..............................................…10

Photosensitivity reactions...............……….11


Feature
New international collaboration for safer use of medicines and better
patient care...12

WHO Prequalification of Medicines Programme: Inspection of Finished
Pharmaceutical Product Manufacturers to increase quality of
medicines...........................16

disponible en

http://www.who.int/entity/medicines/publications/newsletter/2010news2_1.pdf